BTAI Earnings

Quarterly EPS
$-5.15
Q3 2024
$-3.57
Q4 2024
$-1.50
Q1 2025
$-2.45
Q2 2025
$-2.18
Q3 2025
$-0.57
Q4 2025
$-0.54
Q1 2026
$-0.49
Q2 2026
Latest Revenue182.0K
Latest Net Income-14713000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.49182.0K-14713000+51.7%+80.0%
Q1 2026-$0.54206.0K-12691000+22.6%+64.0%
Q4 2025-$0.57256.0K-12545000-30.1%+84.0%
Q3 2025-$2.1898.0K-30911000-54.2%+57.7%
Q2 2025-$2.45120.0K-19187000-89.1%+25.8%
Q1 2025-$1.50168.0K-7254000-71.1%+89.2%
Q4 2024-$3.57366.0K-10859000-2.7%+70.5%
Q3 2024-$5.15214.0K-13650000-37.2%+81.3%
Q2 2024-$3.301.1M-8299000
Q1 2024-$13.89582.0K-26791000
Q4 2023-$12.09376.0K-22256000
Q3 2023-$27.52341.0K-50486000
BioXcel Therapeutics (BTAI) — Earnings